Compare LSPD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSPD | AMPH |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 885.4M |
| IPO Year | 2020 | 2005 |
| Metric | LSPD | AMPH |
|---|---|---|
| Price | $10.59 | $21.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $13.33 | ★ $28.38 |
| AVG Volume (30 Days) | ★ 787.8K | 431.3K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $15.43 | $6.90 |
| Revenue Next Year | $10.94 | $4.64 |
| P/E Ratio | ★ N/A | $26.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.83 | $16.65 |
| 52 Week High | $13.72 | $31.26 |
| Indicator | LSPD | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | 60.69 |
| Support Level | $8.97 | $18.36 |
| Resistance Level | $11.02 | $22.32 |
| Average True Range (ATR) | 0.31 | 0.79 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 48.78 | 62.36 |
Lightspeed Commerce Inc is a one-stop commerce platform providing its customers with the critical functionalities needed to engage with consumers, manage their operations, order their inventory, accept payments, and run their business. It has customers globally in over 100 countries, empowering single- and multi-location small and medium-sized businesses to compete in an omni-channel market environment by engaging with consumers across online, mobile, social, and physical channels. Its products are divided into retail, restaurant, and golf categories. Geographically, it operates in Canada, the United States, the United Kingdom, Switzerland, Germany, and Others with the majority of revenue deriving from Canada.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.